BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 24657303)

  • 21. [Aprospective study of detection and clinical significance of bone marrow tumor cells in small cell lung cancer].
    Wang Y; Lu BH; Gao Y; Liu YX; Hu MM; Che NY; Lin HF; Li HX; Zhang HM; Zhang TM
    Zhonghua Zhong Liu Za Zhi; 2024 May; 46(5):419-427. PubMed ID: 38742355
    [No Abstract]   [Full Text] [Related]  

  • 22. Disseminated tumor cells in bone marrow and circulating tumor cells in blood of breast cancer patients: current state of detection and characterization.
    Riethdorf S; Pantel K
    Pathobiology; 2008; 75(2):140-8. PubMed ID: 18544969
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pooled analysis of the prognostic relevance of disseminated tumor cells in the bone marrow of patients with ovarian cancer.
    Fehm T; Banys M; Rack B; Janni W; Marth C; Blassl C; Hartkopf A; Trope C; Kimmig R; Krawczyk N; Wallwiener D; Wimberger P; Kasimir-Bauer S
    Int J Gynecol Cancer; 2013 Jun; 23(5):839-45. PubMed ID: 23694981
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The prognostic significance of tumour cell detection in the peripheral blood versus the bone marrow in 733 early-stage breast cancer patients.
    Molloy TJ; Bosma AJ; Baumbusch LO; Synnestvedt M; Borgen E; Russnes HG; Schlichting E; van't Veer LJ; Naume B
    Breast Cancer Res; 2011 Jun; 13(3):R61. PubMed ID: 21672237
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Predictive factors for the presence of tumor cells in bone marrow and peripheral blood in breast cancer patients.
    Cabinakova M; Mikulova V; Malickova K; Vrana D; Pavlista D; Petruzelka L; Zima T; Tesarova P
    Neoplasma; 2015; 62(2):259-68. PubMed ID: 25591591
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tumor cell dissemination to the bone marrow and blood is associated with poor outcome in patients with metastatic breast cancer.
    Hartkopf AD; Stefanescu D; Wallwiener M; Hahn M; Becker S; Solomayer EF; Fehm TN; Brucker SY; Taran FA
    Breast Cancer Res Treat; 2014 Sep; 147(2):345-51. PubMed ID: 25151295
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Simultaneous detection of circulating and disseminated tumor cells in primary breast cancer patients following neoadjuvant chemotherapy.
    Walter VP; Taran FA; Wallwiener M; Hahn M; Brucker SY; Hartkopf AD
    Arch Gynecol Obstet; 2018 Mar; 297(3):785-790. PubMed ID: 29380106
    [TBL] [Abstract][Full Text] [Related]  

  • 28. HER2-positive DTCs/CTCs in breast cancer.
    Hartkopf AD; Banys M; Fehm T
    Recent Results Cancer Res; 2012; 195():203-15. PubMed ID: 22527508
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunomagnetic enrichment of disseminated tumor cells in bone marrow and blood of breast cancer patients by the Thomsen-Friedenreich-Antigen.
    Schindlbeck C; Stellwagen J; Jeschke U; Karsten U; Rack B; Janni W; Jückstock J; Tulusan A; Sommer H; Friese K
    Clin Exp Metastasis; 2008; 25(3):233-40. PubMed ID: 18185913
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Detection and prevalence of disseminated tumor cells from the bone marrow of early stage male breast cancer patients.
    Hartkopf AD; Taran FA; Walter CB; Hahn M; Fehm T; Wallwiener M; Brucker SY
    Breast Cancer Res Treat; 2015 Jul; 152(1):51-55. PubMed ID: 26012646
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Significance of micrometastasis in bone marrow and blood of operable breast cancer patients: research tool or clinical application?
    Lang JE; Hall CS; Singh B; Lucci A
    Expert Rev Anticancer Ther; 2007 Oct; 7(10):1463-72. PubMed ID: 17944570
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prognostic role of circulating tumor cells and disseminated tumor cells in patients with prostate cancer: a systematic review and meta-analysis.
    Ma X; Xiao Z; Li X; Wang F; Zhang J; Zhou R; Wang J; Liu L
    Tumour Biol; 2014 Jun; 35(6):5551-60. PubMed ID: 24563278
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Persistence of disseminated tumor cells after neoadjuvant treatment for locally advanced breast cancer predicts poor survival.
    Mathiesen RR; Borgen E; Renolen A; Løkkevik E; Nesland JM; Anker G; Ostenstad B; Lundgren S; Risberg T; Mjaaland I; Kvalheim G; Lønning PE; Naume B
    Breast Cancer Res; 2012 Aug; 14(4):R117. PubMed ID: 22889108
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical significance of circulating tumor cells detected by an invasion assay in peripheral blood of patients with ovarian cancer.
    Fan T; Zhao Q; Chen JJ; Chen WT; Pearl ML
    Gynecol Oncol; 2009 Jan; 112(1):185-91. PubMed ID: 18954898
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Enrichment and detection method for the prognostic value of circulating tumor cells in ovarian cancer: A meta-analysis.
    Huang C; Lin X; He J; Liu N
    Gynecol Oncol; 2021 May; 161(2):613-620. PubMed ID: 33674144
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prognostic significance of disseminated tumor cells in the bone marrow of prostate cancer patients treated with neoadjuvant hormone treatment.
    Köllermann J; Weikert S; Schostak M; Kempkensteffen C; Kleinschmidt K; Rau T; Pantel K
    J Clin Oncol; 2008 Oct; 26(30):4928-33. PubMed ID: 18794550
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Predictive value of circulating tumor cells (CTCs) in newly-diagnosed and recurrent ovarian cancer patients.
    Liu JF; Kindelberger D; Doyle C; Lowe A; Barry WT; Matulonis UA
    Gynecol Oncol; 2013 Nov; 131(2):352-6. PubMed ID: 23954902
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Disseminated tumor cells in bone marrow may affect prognosis of patients with gynecologic malignancies.
    Banys M; Solomayer EF; Becker S; Krawczyk N; Gardanis K; Staebler A; Neubauer H; Wallwiener D; Fehm T
    Int J Gynecol Cancer; 2009 Jul; 19(5):948-52. PubMed ID: 19574790
    [TBL] [Abstract][Full Text] [Related]  

  • 39. EMT-like circulating tumor cells in ovarian cancer patients are enriched by platinum-based chemotherapy.
    Chebouti I; Kasimir-Bauer S; Buderath P; Wimberger P; Hauch S; Kimmig R; Kuhlmann JD
    Oncotarget; 2017 Jul; 8(30):48820-48831. PubMed ID: 28415744
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Detection of Circulating Tumor Cells at Surgery and at Follow-Up Assessment to Predict Survival After Two-Stage Liver Resection of Colorectal Liver Metastases.
    Brudvik KW; Seeberg LT; Hugenschmidt H; Renolen A; Schirmer CB; Brunborg C; Bjørnbeth BA; Borgen E; Naume B; Waage A; Wiedswang G
    Ann Surg Oncol; 2015 Nov; 22(12):4029-37. PubMed ID: 25801354
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.